BioSpace News Archive

Medivir AB announced that Medivir AB has renegotiated its agreement with TetraLogic Pharmaceuticals Corporation regarding financial obligations for birinapant, a SMAC mimetic, for the treatment of solid cancer tumors.

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the extraordinary general meeting on Wednesday 13 January 2021.

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced that yesterday the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive Opinion for Ogluo™.

Blood-Based AlzoSure Assay Has Potential to Transform Management of Alzheimer’s Disease by Identifying Patients Early in the Disease Process

The San Diego office of American Specialty Health Incorporated has been named among San Diego’s “Top Workplaces” in the 8th annual Top Workplaces awards sponsored by the San Diego Union Tribune and Philadelphia-based Energage.

Ohio State University’s Chief of Colon and Rectal Surgery joins Advisory Board at surgical intelligence startup focused on democratizing surgical care

Vizient, Inc. called for the Centers for Medicare and Medicaid Services to delay the start of the recently finalized Most Favored Nation Model for certain physician-administered drugs.

Winning researchers and startup entrepreneurs capture prizes in four categories at Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics conference

The GP2 Phase III clinical trial design was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) and introduced by the Global Principal Investigator, Professor Mothaffar F. Rimawi of Baylor College of Medicine

Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide’s clinical trial for COVID-19.